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Evaluation of Xpert MTB/RIF testing
for rapid diagnosis of childhood pulmonary
tuberculosis in children by Xpert MTB/RIF
testing of stool samples in a low resource
setting
Zahra Hasan1* , Sadia Shakoor1, Fehmina Arif2, Aisha Mehnaz2, Alnoor Akber1, Marium Haider2, Akbar Kanji1
and Rumina Hasan1

Abstract
Objective: Children with tuberculosis (TB) remain underdiagnosed due to difficulty in testing for Mycobacterium
tuberculosis (MTB) infection. We evaluated the Xpert MTB/RIF assay for respiratory and stool testing in children for pulmonary TB through a cross-sectional study at tertiary care facilities in Karachi, Pakistan. Fifty children aged 0–15 years
screened by a modified Kenneth-Jones (KJ) score were included. Mycobacterial culture of respiratory samples was
the microbiological standard against stool Xpert TB results. All positive TB cases were compared against a treatment
response standard (TRS).
Results: Twelve study subjects were diagnosed by Xpert TB and nine by MTB culture. Compared with culture [gastric
aspirates (GA)/sputum (spm)], stool Xpert TB had a sensitivity of 88.9% (95% CI 50.7–99.4) and a specificity of 95%
(95% CI 81.8–99.1). Xpert TB stool versus GA/spm had sensitivity of 81.8% (95% CI 47.8–96.8) and specificity of 94.7%
(95% CI 84.6–99.9). We found good agreement (kappa scores of >0.8) between stool Xpert, GA/spm Xpert and GA/
spm culture. Stool Xpert PPV and NPV against TRS was 100 and 82.1% respectively. Stool Xpert TB is a relatively easy
option for diagnosis for pulmonary childhood TB in a high burden low-resource setting.
Introduction
Pakistan ranks 5th amongst high tuberculosis (TB) burden countries and 36% of its population comprises children under 15 years. At least 1 million children fall ill
with TB each year. Children represent about 11% of all TB
cases [1]. The incidence of TB in Pakistan is 255/100,000
in adults and 46/100,000 in children [1]. Under-diagnosis
and under-reporting of TB occurs in children. Diagnosis
is often based on clinical signs with algorithms of exposure to TB and chest X-ray (CXR) and immunological
reactivity [2, 3]. Microbiological confirmation of TB in
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young children is difficult due to the problems in obtaining appropriate respiratory specimens; young children do
not produce sputum and it is difficult to collect invasive
specimens such as gastric aspirates (GA).
Xpert MTB/RIF assay (Cepheid Sunnyvale, USA)
allows simultaneous detection of Mycobacterium tuberculosis (MTB) and rifampicin resistance, with a pooled
sensitivity of 89% for pulmonary TB in adults [4]. In children, the pooled sensitivities and specificities of Xpert for
TB detection using respiratory specimens and GA compared with culture, was 62–66 and 98%, respectively
[5]. Nicol et al. describe the effectiveness of Xpert stool
testing in children compared with induced sputum and
GA with a sensitivity of overall 47%, with 80% in HIV
infected and 33% in non-HIV infected children [6]. Here,
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we investigated stool-based Xpert as alternate to respiratory samples from non-HIV children suspected of pulmonary TB.

Main text
Methods

The study was conducted at Civil Hospital Karachi
(CHK), Dow University of Health Sciences (DUHS), and
The Aga Khan University Hospital (AKUH), Karachi,
Pakistan (October 2014 to November 2015). CHK is a
tertiary care public hospital with pediatric units including, a TB clinic linked with the National Tuberculosis
Control Program Pakistan (NTP). The AKUH-Pakistan
is a tertiary care teaching hospital. This was a cross-sectional study with convenience sampling method.
Children up to 15 years of age suspected to have pulmonary tuberculosis were screened for the study based
on clinical symptoms including, history of fever, cough,
weight loss and abdominal distention. Subsequently, a
physical exam and chest Xray were performed. Patients
were further assessed according to the diagnostic algorithm utilized by the Pakistan Pediatric Association
which is based on the NTP case management deskguide
[3]. This is a modified Kenneth-Jones (KJ) criteria (Additional file 1: Table S1) [2] and scores patients according
to their ‘risk’ assessment based on the presence of risk
factors such as, contact with an adult TB patient, lack of
BCG vaccination, the occurrence of measles infection,
PCM grade III and immune compromise due to malignancies or steroid treatment. We enrolled patients with
a KJ score of ≥5 subject to informed consent. One respiratory and stool sample was collected per child. Gastric
aspirates (GA) were collected early morning nasogastric intubation following an overnight fast. GA samples
were tested by Xpert TB and MTB culture and sensitivity
(MTBCS). In patients who produced sputum (spm) years
this specimen was utilized instead of GA for Xpert TB
and MTBCS.
GA samples collected at CHK were transported to
AKUH and processed within 24 h. GA samples were
divided into two parts; one was neutralized with 4%
sodium carbonate, digested-decontaminated with
N-acetyl-L-cystine and 4% sodium hydroxide, centrifuged at 3000 g to set up MTB culture using liquid
mycobacterial growth indicator tube (MGIT) 960 system (Becton–Dickinson, USA). Mycobacterial culture
and drug susceptibility testing (DST) were performed
as described previously [7]. The second part of the respiratory sample was diluted 2:1 in Xpert sample reagent,
shaken vigorously, incubated at room temperature for
15 min and added to the Xpert cartridge.
Stool was collected within 24 h of GA samples, stored
at 2–8 °C, transported to AKUH and stored at −80 °C
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until processed as described previously [6]. Briefly, 0.15 g
of thawed stool was placed in 2.4 mL phosphate buffered
saline (PBS) and vortexed, left undisturbed for 20 min
at room temperature before a 1 mL supernatant was
removed, centrifuged at 3500 rpm for 15 min. The supernatant was discarded and pellet re-suspended in 1 mL
PBS, then diluted 2:1 in sample reagent and added to the
Xpert cartridge. Xpert GA results were reported to physicians within 24 h of processing.
Study subjects were diagnosed with TB based on a
positive microbiological test result (a positive MTB culture and/or positive Xpert MTB/RIF on gastric aspirate). In addition, some were given empirical treatment
based on the evaluation by the treating pediatrician. TB
patients were treated according to the Pakistan Pediatric
Association guidelines for TB; 2 months of isoniazid (H),
rifampicin (R), pyrazinamide (Z) and ethambutol (E) followed with 4 months HR. All patients were followed by
regularly every 4–6 weeks and underwent history taking
and physical examination. Children were evaluated for
adherence to treatment response to treatment (resolution
of symptoms, weight gain, radiographic improvement)
and monitored for adverse reaction to medications. End
of treatment follow up was conducted either in clinic or
over the telephone for out of town study subjects.
Patient demographics, Xpert TB and MTBCS results
were entered in MS Excel. Xpert stool and Xpert respiratory sample sensitivities were derived by comparing to
respiratory culture. FDA Statistical guidance on reporting results from studies evaluating diagnostic tests was
used to calculate sensitivity and specificity of the assay
and positive and negative percent agreements (PPA,
NPA) with kappa scores [8].
Response to empiric anti-tuberculous treatment (ATT)
in children who tested negative for microbiological diagnosis (negative TB culture and negative Xpert) was considered as evidence for TB [9, 10]. We used this criterion
as a Treatment Response Standard (TRS) to determine
the positive predictive value (PPV) and negative predictive value (NPV) and specificity of Xpert in stool. Data
was analysed and parameters calculated in MS Excel. [8].
Results

A total of sixty-four children were assessed of which fifty
were found to fit the study criteria with a KJ score of ≥5,
(Fig. 1). Study subjects included 28 males and 22 females
(Table 1 and Additional file 2: Table S2) and ages ranging from 7 months to 15 years. The Median (Interquartile
range) age of the children was 6.8 (9–2) years. Fifty-four
percent (54%; n = 27) of child TB subjects had contact
with an adult TB patient. Only 46% (n = 23) of children
had a history of BCG vaccination based on parental recall
and 30% (n = 15) had a BCG scar. Two children had a
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Study subjects screened based on clinical
history (n=64)
Subjects excluded with KJ score<5 (n=14)

#Subjects recruited for microbiological tesng
based on KJ≥5 (n=50)

50 respiratory samples; GA n=48, sputum
(n=2)
GA; MTBC pos (n=9); TB Xpert pos (n=11)

Sputum; MTBC, neg (n=2), TB Xpert neg
(n=2)
N=49 stool samples tested by TB Xpert *

Stool; TB Xpert pos (n=11); neg (n=38)

Posive TB diagnosis; microbiology posive
(n=12); empirical ATT (n=6)
Follow of response to treatment; 17 TB paents
were noted to show clinical improvement**

Fig. 1 Outline of study. ‘#’ additional tests done for this study together with routine GA/sputum MTB culture were TB Xpert on GA/sputum and stool
specimens of each study subject; asterisk one study subject expired prior to collection of stool sample; double asterisk end of treatment follow up
was available for 17 cases only as one study subject expired

history of measles in the 6 months preceding the presenting illness. Forty-six percent (n = 23) of the total group
and 61% (n = 14) of under 5 year olds suffered from
protein calorie malnutrition (PCM) grade 3. Thirty percent (n = 15) of the overall group and 39% (n = 9) of the
under 5 year group were immune-compromised due to
steroid treatment, immune-deficiencies or malignancies.
Human immunodeficiency virus (HIV) testing was not
performed in the study subjects.
In total 48 GA and 2 spm samples were collected. Stool
samples were collected in 49 cases and could not be collected in one case where the subject had expired. Paired
respiratory (GA/spm) and Stool samples were available for 49 cases described in Additional file 2: Table S2.
All MTB cultures were drug susceptible and similarly,
rifampicin resistance was not detected in Xpert positive
samples. Microbiological testing of GA samples showed
11 positive cases by Xpert and 9 positive cases by MTBC.
The 2 sputum samples were negative by both Xpert and
MTBC. Stool Xpert testing revealed 10 positive cases.
Table 1 shows results of Xpert GA and stool testing using
Xpert and GA MTB culture amongst study subjects.
Overall, 12 children were diagnosed with TB based
on microbiological tests and an additional 6 children
were diagnosed clinically. All of the eighteen TB cases
were prescribed empirical first-line ATT. One child died
after 1 month of ATT due to an unrelated accident. The
remaining 17 TB cases showed clinical improvement.

When compared with GA culture standard, Xpert in
stool had a sensitivity of 88.9% (95% CI 50.7–99.4) and a
specificity of 95% (95% CI 81.8–99.1), Table 2.
Xpert GA versus culture had sensitivity of 100% (95%
CI 62.9–100) and specificity of 95% (95% CI 81.8–99.1).
Xpert stool vs GA had sensitivity 81.8% (95% CI 47.8–
96.8) and specificity 94.7% (95% CI 80.9–99.1). There
was very good agreement (kappa scores of >0.8) between
stool Xpert and GA Xpert and GA culture.
Sensitivity, specificity, PPV, and NPV of GA and stool
Xpert were also calculated with a treatment response
standard (TRS). Xpert in stool had a sensitivity of 58.8%
(95% CI 33.5–80.6), specificity of 100% (86.7–100), PPV
of 100% (95% CI 65.5–100) and NPV of 82.1% (95%
CI 65.9–91.9) against a TRS. Overall percent positive and
negative agreements of stool Xpert with GA culture &
GA Xpert and Cohen’s kappa is calculated and presented
as part of Table 2.
Discussion

There is a high burden of largely underdiagnosed childhood TB in South Asian countries including, Pakistan
[11]. There is a need for rapid, easy diagnostics for child
TB in such settings. National guidelines for TB care in
Pakistan recommend the use of Xpert as an initial test for
diagnosis TB in children. However, due the difficulty in
obtaining suitable specimens for testing diagnosis of TB
in children has generally been low [12].

19

8

50

6–10 years

11–15 years

Total

100

16

38

46

% of each age
group (n = 50)

28 (56)

5 (63)

11 (58)

12 (52)

23 (46)

2 (25)

10 (53)

11 (48)

TB contact (%) BCG vaccination
(%)

Subjects for whom both GA and stool analysis were available were included

23

0–5 years

a

Number each
age group

Age group

15 (30)

3 (38)

7 (37)

5 (22)

2 (4)

–

1 (5)

1 (4)

23 (46)

3 (38)

6 (32)

14 (61)

15 (30)

4 (50)

2 (11)

9 (39)

BCG scar (%) Measles (%) PCM III (%) Immune compromised (%)

Table 1 Characteristics of study subjects tested for MTB by Xpert TB/RIF assay or MTB culture
GA MTBCS
(n = 49)a

STOOL
Xpert
(n = 49)a

11

2

3

7

22.4

25

15.7

31.8

9

1

3

5

18.3

14.3

15

22.7

10

3

2

5

20.4

50

10

27.3

Pos % Pos Pos % Pos Pos % Pos

GA Xpert
(n = 49)a

Hasan et al. BMC Res Notes (2017) 10:473
Page 4 of 6

Hasan et al. BMC Res Notes (2017) 10:473

Page 5 of 6

Table 2 Performance characteristics of Xpert in stool in comparison with culture and gastric aspirate Xpert standards
Test

Reference standard Number of patients
included in evaluation

Sensitivity % (95%
CI)

Stool Xpert

GA culture

49

88.9 (50.7–99.4)

49

100 (62.9–100)

49

81.8 (47.8–96.8)

GA Xpert
GA Xpert

Stool Xpert

Specificity % (95%
CI)

PPA (%)

NPA (%)

Kappa agreement
(95% CI)

95 (81.8–99.1)

88.9

95

0.804 (0.592–1.00)

95 (81.8–99.1)

100

95

0.875 (0.706–1.00)

97.4 (84.6–99.9)

81.8

97.3

0.818 (0.62–1.00)

Sensitivity, specificity, 95% confidence intervals (CI), positive percent agreement (PPA), and negative percent agreement (NPA), and kappa scores were calculated in
MS Excel

Here, we show that Xpert testing of stool has comparable performance and good agreement with Xpert GA
testing in a cohort of children with high probability of
pulmonary TB. Our data is in line with previous reports
[6], including a recent systematic review of Xpert-based
childhood TB diagnosis with pooled sensitivity of 62% for
respiratory specimens (5).
We observed the sensitivity of stool Xpert to be 88.9%
as compared with GA culture, 100% with GA Xpert and
81.8% with GA Xpert. The stool Xpert sensitivity we
observed was higher than that shown by Nicol et al. in
non-HIV children [6] and by Chipinduro et al. in HIV
and non-HIV children [13] possibly, due to the screening
tool (modified KJ score) we used to recruit children with
high likelihood of TB. However, the sensitivity of Xpert
stool we observed was similar to that reported by Banada
et al. [14] who tested larger quantities of replicate stool
samples from children with pediatric TB. A limitation of
our study was that we were able to only collect one set
of stool and GA samples. Marcy et al. showed that when
additional respiratory samples such as, nasopharyngeal
aspirates were taken together with stool Xpert the sensitivity was increased by 10%, improving chances of TB
diagnosis [15].
The NTP has installed more than 50 Xpert machines
installed in selected tertiary, secondary care hospitals
and specialized TB clinics. As stool is easily obtained we
hope that this work can be extended to implementation
in the NTP, allowing the described method to be implemented in a decentralized setting. It would be most effective to combine stool Xpert with testing of additional
respiratory samples (GA, NPA) by Xpert for the diagnosis of childhood TB as it is highly likely to improve yield
of TB diagnosis. Overall, we show that stool Xpert testing
can improve microbiological diagnosis and confirmation
of TB in children at high risk for TB in the local setting.
Limitations

Due to the limited study budget the sample size of the
study was relatively small. Also, we were only able to
collect a single stool sample rather than successive daily

samples. HIV testing was not performed on the study
subjects.

Additional files
Additional file 1: Table S1. Modified Kenneth Jones Score/ Pakistan
Paediatrics Association scoring chart for diagnosis of TB in children. ‘0-2’ TB
unlikely; ‘3-4’ Keep under observation for possible TB for 3 months; ‘5-6’ Tuberculosis possible (Investigations may justify therapy; ‘7’ or more TB probable and
needs to be confirmed. ‘*’ Include children with malignancies (leukemias,
lymphomas), immunodeficiencies, and immunosuppressive therapy such
as chronic steroids more than 2 weeks. PCM Grade 3= Protein Calorie Malnutrition grade 3 not improving after 4 weeks of adequate caloric intake.
‘**’ Physical Examination Suggestive of TB: Pulmonary findings (unilateral
wheeze, dullness), hepatosplenomegaly, ascites; Strongly suggestive of
TB: Matted lymphadenopathy, abdominal mass, gibbus formation, chronic
monoarthritis, CNS findings (bulging fontanelle, irritability, papilledema).
‘†’ Radiological findings: Nonspecific: Ill-defined opacity/infiltrates; marked
broncho-vascular marking. Suggestive of TB: Consolidation not responding to antibiotic therapy; paratracheal, tracheal, or mediastinal lymphadenopathy, miliary mottling.
Additional file 2: Table S2. Characteristics of Pediatric Study subjects
enrolled for TB testing. Data was compiled as per information collected
from Modified Kenneth Jones Score sheet (Additional file 1: Table S1). The
presence of an identifier is, “1” and absence is, “0”; na, not available.
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Xpert TB: Xpert MTB/RIF assay, Cepheid, USA; TB: tuberculosis; MTB: Mycobacterium tuberculosis; KJ: Kenneth-Jones; GA: gastric aspirates; Spm: sputum; TRS:
treatment response standard; PPV: positive predictive value; NPV: negative
predictive value; CXR: chest X-ray; CHK: Civil Hospital Karachi; DUHS: Dow
University of Health Sciences; AKUH: The Aga Khan University Hospital; NTP:
National Tuberculosis Control Program Pakistan; MGIT: Mycobacterial Growth
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